Investors

Conduction of IPO has been planned with further entry to the Hong Kong Stock Exchange by 2025.

We guarantee our partners:

  • Prompt establishment of modern high-tech product manufacturing, equipped with international standards;
  • High quality products that have undergone three-factor verification before sales launch;
  • Equally fast delivery for both large and small lots of products;
  • Convenient individual conditions of cooperation;

We invite you to become our partner!

Investors
Name Koru Pharmaceuticals Co., Ltd
Turnover in 2018 7 million USD
Turnover in 2019 11 million USD
Staff 60 employees
Work Geography Over 80 countries
Number of Laboratories 4
Number of suppliers 220
Number of products Over 200
Number of Logistics Warehouses  3

Contact us

Apply now and our manager will get in touch with you shortly.
* — must be filled in.

On details regarding investment, you can also contact us at the following address: finance@korupharma.com